IMU

0.00%

5.9¢ imugene limited

Media Thread, page-12579

First 12579 Last

Share
Profile

Follow
kingkev

27,375 Posts.

1290

22/03/24

08:03

Post #: 73005568
Share

Originally posted by Taureanbull: ↑

Hawkbar, The company doesn’t need to arrive at its final destination for the share price to move. As I have pointed out several times, the company does want to move onto the NASDAQ. It does have major international investors watching the OASIS trial closely. The company has also employed a corporate strategist.. A lot of money has already been spent preparing for a NASDAQ listing. And we have several trial results for our platforms being released this year.

The stock market is very cable of relating a stock without seeing a big pharma deal. This company has made incredible progress in the last two years. At some stage this progress will be reflected in the share price, Whilst it may seem like it’s sat idle forever this does not predict forward shareprice movement. As with the big effort to push our clinical programs ahead, after we get the results released, the company will use these results as a catalyst to push our ahead our corporate strategy and the share price will respond accordingly.

There is a reason we are seeing this flurry of media activity. Did you also note in the last video of Leslie Chong, mentioned “ a recent presentation to US investors”. Whilst we haven’t seen a video, posted here and do not have any further information, it does hint that she is presenting to them. And it’s unlikely to be Mums and Dads . The US has a quite large and sophisticated BIOTECH focussed investment community. As opposed to Australia that has a very thin sprinkling of mums and dads.

It’s very much my experience that the SP,of a successful Biotexh will rerate rapidly when institutional investors come on board . This hasn’t happened to IMU as yet, in part because dour domestic fund managers don’t touch Biotexh. But US investors have a huge appetite for future disruptive technologies.

And that is exactly what IMU is about to unveil. The results of trials . That’s is why they dumped ALA , because our drugs are so good they don’t need ALA. All of this has been presented in the 4 videos and assorted other social media posts and announcements.

I personally got a lot from Dr Bradley Glovers presentation. And further as I shared with this board, I was lucky enough to have the opportunity to meet him and ask why he joined IMU. He reinforced his reasons again yesterday.

As he is a highly qualified expert on Celular Therapies , I’m very happy to take his word , that we have an amazing portfolio of assets here, And I’m happy to trust that major investors will see this opportunity resulting in a major relating of our share price.A Market Cap of just US$520M is clearly ridiculously low.

Expand

all good and in the meantime we hope we can hold on to 11c

IMU Price at posting: 11.0¢ Sentiment: Buy Disclosure: Held
6 Upvote

0 Great analysis

Reply

Top Stories

AML

Cultural heritage agreement puts Walford Creek exploration back on the map

FHE

Frontier Energy achieves key milestone for Waroona energy project

BRX

Belararox delineates another porphyry in Argentina at Tambo South

RDN

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

STX

Strike Energy secures $153 million for Perth Basin gas projects

SBW

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

EMD

Emyria's Empax Centre chosen for mental health clinical trial

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

There are more pages in this discussion • 1,713 more messages in this thread...

First 12579 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.9¢		Change 0.000(0.00%)		Mkt cap ! $431.8M

Open	High	Low	Value	Volume
5.9¢	5.9¢	5.6¢	$1.037M	17.94M

Buyers (Bids)

No.	Vol.	Price($)
8	1882949	5.8¢

Sellers (Offers)

Price($)	Vol.	No.
5.9¢	399643	3

View Market Depth

No.	Vol.	Price($)
7	1874329	0.058
9	1728227	0.057
23	4466894	0.056
27	3648665	0.055
8	305000	0.054

Price($)	Vol.	No.
0.059	1360	1
0.060	2622845	17
0.061	773907	4
0.062	2227969	6
0.063	243179	3

Last trade - 16.10pm 21/06/2024 (20 minute delay)

IMU (ASX) Chart

Media Thread, page-12579

Cultural heritage agreement puts Walford Creek exploration back on the map

Frontier Energy achieves key milestone for Waroona energy project

Belararox delineates another porphyry in Argentina at Tambo South

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Strike Energy secures $153 million for Perth Basin gas projects

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Emyria's Empax Centre chosen for mental health clinical trial

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media Thread, page-12579

Top Stories

Cultural heritage agreement puts Walford Creek exploration back on the map

Frontier Energy achieves key milestone for Waroona energy project

Belararox delineates another porphyry in Argentina at Tambo South

If you thought lithium was dead, think again. The Pilbara will be central to the next upswing

Strike Energy secures $153 million for Perth Basin gas projects

Shekel Brainweigh CEO Nir Leshem weighs in on AI adoption ahead of FY25

Emyria's Empax Centre chosen for mental health clinical trial

With financials holding the fort, materials must step up with some heavy lifting to stimulate stocks

ASX Market Update: Shares fall flat as GYG soars on debut | 20 June, 2024

Plagues precede widespread power shifts. We’re living in one – and minerals are at the fore

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News